For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

NCI COVID

Trial Overview

Official Title

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study

Study Purpose

To collect blood samples, information, and medical images from patients who are being treated for cancer and have COVID-19. Researchers will use these blood samples, information, and medical images to answer the questions: How does COVID-19 affect the outcomes of people undergoing cancer treatment and how does having cancer affect COVID-19? 

Diagnosis

Patients who are receiving treatment for cancer and have been tested for COVID-19. You are either waiting for the results of this test or you already have a positive test result.

Eligibility

Current cancer patients who are receiving systemic, radiation, or adjuvant therapy, and patients who have received an autologous transplant within the past 2 years.

Patient must have had a COVID19 test performed or had a positive COVID19 result in the last 14 days.

Patients must sign an approved informed consent and authorization permitting release of personal health information.

Intervention

Data collection, periodic study blood collection, and imaging submission for up to 2 years from enrollment.

Study blood is only collected when other blood is being drawn.

Imaging is submitted if it is completed as part of the normal patient care.

No extra study visits are required.

For more information, visit ClinicalTrials.gov

Key Participation Requirements
Gender
Male or Female
Age
19 years and older
Phase
Not Applicable
Methodist Health System Trial Code
NCICOVID
Related Specialties